4,536
Views
24
CrossRef citations to date
0
Altmetric
Review

Efflux pump inhibitors as a promising adjunct therapy against drug resistant tuberculosis: a new strategy to revisit mycobacterial targets and repurpose old drugs

, & ORCID Icon
Pages 741-757 | Received 24 Feb 2020, Accepted 22 Apr 2020, Published online: 20 May 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.